Newsby HottubFor agents

Health

Food and Drug Administration distributes letter on safety of GLP-1 obesity treatment

“시력 줄어들 위험 있다” 식약처, GLP-1 비만치료제 안전성 서한 배포

18 outletsin 1 language and 1 countryFirst reported , latest

People and organizations

Named in this story's headlines. Add any of them to CRM by Hottub; nothing is saved until you press Add there.

Every report 22 reports

  1. “시력 줄어들 위험 있다” 식약처, GLP-1 비만치료제 안전성 서한 배포

    Food and Drug Administration distributes letter on safety of GLP-1 obesity treatment

    Kormedi.comKR

    Add to CRM
  2. 미 FDA, 위고비 등 비만치료제 ‘시력 상실 위험’ 경고 의무화

    US FDA mandates warning for obesity drugs like Wegovy about 'risk of vision loss'

    The HankyorehKR

    Add to CRM
  3. “살 빼려다 시력 잃을 수도”…美 FDA, 비만치료제에 ‘실명 위험’ 경고 의무화

    "Trying to lose weight could lead to blindness"... US FDA mandates 'blindness risk' warning for obesity drugs

    Maeil Business NewspaperKR

    Add to CRM